What does the published scientific research say about Streptomyces albus?
Eight PubMed articles reference Streptomyces albus in a plant-input context, covering fungal biocontrol, secondary metabolite production, and host-plant resistance induction. Named strains studied include XJC2-1, RC2, CAI-17, KAI-27, and CAI-21, giving the literature a strain-level specificity useful for product research.
Secondary metabolites are a recurring subject. CAI-21's culture filtrate yielded an organophosphate compound shown to inhibit M. phaseolina growth. Genomic analysis of RC2 identified 15 biosynthetic gene clusters and several novel secondary metabolites by UPLC-HRMS. Cited mechanisms include direct hyphal destruction, sporangium and zoospore suppression, and upregulation of host antioxidant enzymes including superoxide dismutase and catalase.
Beyond fungal disease, the indexed literature includes an endophytic S. albus strain (GA) reported to cause over 90% mortality in cotton aphid (Aphis gossypii), and a marine isolate (A66) shown to inhibit Vibrio biofilm formation relevant to aquaculture applications.
See the full picture on Streptomyces albus
This is one lens. Every connected source on Streptomyces albus in one place: AAPFCO Biostimulant, Biosafety Level, Scientific Literature, Potential Claims, Taxonomy & Synonyms.